Literature DB >> 1704059

Basic approaches to anti-retroviral treatment.

E De Clercq1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1704059

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN： 0894-9255


× No keyword cloud information.
  9 in total

Review 1.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

Review 2.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

3.  The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals.

Authors:  V Dolce; G Fiermonte; M J Runswick; F Palmieri; J E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

Review 4.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

5.  Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.

Authors:  J F Mayaux; A Bousseau; R Pauwels; T Huet; Y Hénin; N Dereu; M Evers; F Soler; C Poujade; E De Clercq
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 6.  Anti-AIDS drug development: challenges and strategies.

Authors:  P Mohan
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

Review 8.  Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).

Authors:  R Whittington; R N Brogden
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

9.  Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses.

Authors:  Franziska Schandock; Camilla Frich Riber; Annika Röcker; Janis A Müller; Mirja Harms; Paulina Gajda; Kaja Zuwala; Anna H F Andersen; Kaja Borup Løvschall; Martin Tolstrup; Florian Kreppel; Jan Münch; Alexander N Zelikin
Journal:  Adv Healthc Mater       Date:  2017-09-25       Impact factor: 9.933
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.